Illumina Inc (ILMN.OQ)

ILMN.OQ on NASDAQ Stock Exchange Global Select Market

183.71USD
4:00pm EDT
Change (% chg)

$-5.88 (-3.10%)
Prev Close
$189.59
Open
$190.04
Day's High
$193.53
Day's Low
$183.31
Volume
452,561
Avg. Vol
353,465
52-wk High
$213.30
52-wk Low
$128.40

ILMN.OQ

Chart for ILMN.OQ

About

Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research... (more)

Overall

Beta: 0.82
Market Cap(Mil.): $27,307.79
Shares Outstanding(Mil.): 144.04
Dividend: --
Yield (%): --

Financials

  ILMN.OQ Industry Sector
P/E (TTM): 65.45 37.60 41.71
EPS (TTM): 2.90 -- --
ROI: 18.33 6.99 16.20
ROE: 26.90 11.12 17.00
Search Stocks

BRIEF-Merck Serono, Illumina to collaborate on cancer diagnostics

* Merck Serono and Illumina enter strategic collaboration for diagnostics in oncology

10 Mar 2015

Illumina teams with U.S. government, researchers to sequence Ebola

CHICAGO - Gene sequencing equipment maker Illumina has teamed up with the U.S. government and academic researchers at the Broad Institute in Boston to train scientists in West Africa to improve tracking of how the Ebola virus is mutating in hopes of fighting it more effectively.

19 Nov 2014

Illumina teams with U.S. government, researchers to sequence Ebola

CHICAGO, Nov 19 - Gene sequencing equipment maker Illumina has teamed up with the U.S. government and academic researchers at the Broad Institute in Boston to train scientists in West Africa to improve tracking of how the Ebola virus is mutating in hopes of fighting it more effectively.

19 Nov 2014

BRIEF-Biomerieux agrees with Illumina to launch NGS epidemiology solution for service labs

* Signs exclusive agreement with Illumina to launch a next-generation sequencing (NGS) epidemiology solution for service labs

18 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks